Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Journal of Molecular Medicine (Berlin, Germany)|September 1, 2005
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tractFederico Massa, Martin Storr, Beat Lutz
Sensors (Basel, Switzerland)|July 26, 2020
LiDAR-Based GNSS Denied Localization for Autonomous Racing CarsFederico Massa, Luca Bonamini, Alessandro Settimi, et al.
Clinical Nuclear Medicine|February 25, 2021
FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration: A Semiquantitative AnalysisFederico Massa, Laura Filippi, Luana Benedetti, et al.
Neuroscience|March 16, 2020
Synaptic Functions of Type-1 Cannabinoid Receptors in Inhibitory Circuits of the Anterior Piriform CortexGeoffrey Terral, Marjorie Varilh, Astrid Cannich, et al.
Scientific Reports|June 28, 2016
Layer-specific potentiation of network GABAergic inhibition in the CA1 area of the hippocampusMichelangelo Colavita, Geoffrey Terral, Clement E Lemercier, et al.
Molecular Metabolism|August 18, 2019
mTORC1 and CB1 receptor signaling regulate excitatory glutamatergic inputs onto the hypothalamic paraventricular nucleus in response to energy availabilityWilfrid Mazier, Nicolas Saucisse, Vincent Simon, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 30, 2021
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegenerationNerea Gómez de San José, Federico Massa, Steffen Halbgebauer, et al.
European Journal of Pharmacology|September 17, 2002
Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypesEnrico Sanna, Fabio Busonero, Giuseppe Talani, et al.
Journal of Alzheimer'S Disease : JAD|May 12, 2020
Brain Aging, Cardiovascular Diseases, Mixed Dementia, and Frailty in the Oldest Old: From Brain Phenotype to Clinical ExpressionGianmarco Rosa, Chiara Giannotti, Lucia Martella, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 11, 2022
Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatmentsFederico Massa, Diego Franciotta, Stefano Grisanti, et al.
Pageof 13